Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech's pivotal trial of vismodegib in advanced basal cell carcinoma meets primary endpoint

March 21, 2011

Polaris begins enrollment in phase II trial of ADI-PEG 20 in malignant mesothelioma

March 21, 2011

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

March 21, 2011

Nerviano enters into oncology license agreement with Novartis

March 21, 2011

New B-raf inhibitors reported by Array BioPharma and Genentech

March 21, 2011

SPINK1 identified as potential therapeutic target in prostate cancer

March 21, 2011

Phase I trial of AZD-8055 in subjects with recurrent gliomas to begin this month

March 18, 2011

Antisense Therapeutics continues seeking partner for ATL-1101 in prostate cancer

March 18, 2011

Senesco's study of SNS01-T in multiple myeloma on hold by FDA

March 18, 2011

Ariad and Merck & Co. to copromote ridaforolimus for sarcoma in U.S.

March 18, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...